Targeting the Progression of Parkinson's Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-6190|7|1|9-36

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.7, Iss.1, 2009-03, pp. : 9-36

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Levodopa/carbidopa and Parkinson's disease progression

By  

Inpharma, Vol. 1, Iss. 1468, 2004-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Motor complications, levodopa metabolism and progression of Parkinson's disease

By Müüller Thomas  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 7, 2011-07 ,pp. : 847-855

Informa Healthcare

Access to resources Recommend Favorite

Ubidecarenone may slow progression of Parkinson's disease

By  

Inpharma, Vol. 1, Iss. 1361, 2002-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Targeting Nicotinic Receptors for Parkinson's Disease Therapy

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 6, 2011-09 ,pp. : 651-658

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Alpha-Synuclein for the Treatment of Parkinson’s Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 2, 2012-03 ,pp. : 174-179

Bentham Science Publishers

Access to resources Recommend Favorite